Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Conference News AHA 2021

Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years

Caitlin E. Cox

November 13, 2021

News Conference News AHA 2021

AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients

L.A. McKeown

November 13, 2021

News Conference News AHA 2020

TAVR Length of Stay Declines, but Readmissions for New Pacemakers Increase

Michael O'Riordan

November 10, 2020

News Conference News AHA 2019

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Yael L. Maxwell

November 18, 2019

News Conference News AHA 2019

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

Yael L. Maxwell

November 16, 2019

News Conference News AHA 2018

Complications Following TAVR Are Going Down, US Data Show

Yael L. Maxwell

November 20, 2018

News Conference News AHA 2017

More Support for TMVR After Failed Mitral Bioprostheses

Yael L. Maxwell

November 23, 2017

News Conference News AHA 2017

AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More

Shelley Wood

November 09, 2017

News Conference News AHA 2016

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Shelley Wood

November 28, 2016

News Conference News AHA 2016

Interatrial Shunt Device Shows Sustained Improvement in Heart Failure Patients With Preserved EF

Shelley Wood

November 16, 2016

Presentation AHA 2016

Transcatheter Intracardiac Shunt Device Provides Sustained Clinical Benefit at One Year in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial

Presenter: David M Kaye

November 15, 2016

News Conference News AHA 2016

Stark Mortality Differences Seen in GARY Registry Tracking TAVR and Surgical Replacement

Shelley Wood

November 14, 2016

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Conference News AHA 2015

Leadless Transcatheter Pacing Looks Good in the Short-term, But Long-term Questions Remain

Yael L. Maxwell

November 09, 2015

News Conference News AHA 2015

CANOA: Fewer Migraines With Clopidogrel Plus Aspirin Post-ASD Closure

Shelley Wood

November 08, 2015

News Conference News AHA 2015

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

Shelley Wood

November 05, 2015

News Conference News AHA 2013

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

November 24, 2013

News Conference News AHA 2013

Registry Study Summarizes Initial US Experience with First Approved TAVR Device

Jason Kahn

November 16, 2013

News Conference News AHA 2012

Early Study Shows Positive Clinical Results with Novel Renal Denervation Device

Jason Kahn

November 04, 2012

News Conference News

Study Looks at Surgery vs. Transcatheter Treatment for Aortic Stenosis Plus CAD

November 15, 2011

Advertisement

Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years

AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients

TAVR Length of Stay Declines, but Readmissions for New Pacemakers Increase

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

Complications Following TAVR Are Going Down, US Data Show

More Support for TMVR After Failed Mitral Bioprostheses

AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Interatrial Shunt Device Shows Sustained Improvement in Heart Failure Patients With Preserved EF

Transcatheter Intracardiac Shunt Device Provides Sustained Clinical Benefit at One Year in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial

Stark Mortality Differences Seen in GARY Registry Tracking TAVR and Surgical Replacement

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Leadless Transcatheter Pacing Looks Good in the Short-term, But Long-term Questions Remain

CANOA: Fewer Migraines With Clopidogrel Plus Aspirin Post-ASD Closure

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

Registry Study Summarizes Initial US Experience with First Approved TAVR Device

Early Study Shows Positive Clinical Results with Novel Renal Denervation Device

Study Looks at Surgery vs. Transcatheter Treatment for Aortic Stenosis Plus CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content